← FDA DRUG APPROVALS

FDA NDA · NDA019713

AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINER

Sponsor: ABBOTT

APPLICATION
NDA019713
TYPE
NDA
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

AMINOSYN II 3.5% IN DEXTROSE 25% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 3.5%, DEXTROSE 25GM/100ML · INJECTABLE · INJECTION
AMINOSYN II 4.25% IN DEXTROSE 20% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, DEXTROSE 20GM/100ML · INJECTABLE · INJECTION
AMINOSYN II 3.5% IN DEXTROSE 5% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 3.5%, DEXTROSE 5GM/100ML · INJECTABLE · INJECTION
AMINOSYN II 4.25% IN DEXTROSE 25% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, DEXTROSE 25GM/100ML · INJECTABLE · INJECTION
AMINOSYN II 5% IN DEXTROSE 25% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 5%, DEXTROSE 25GM/100ML · INJECTABLE · INJECTION
AMINOSYN II 4.25% IN DEXTROSE 10% IN PLASTIC CONTAINERDiscontinued
AMINO ACIDS 4.25%, DEXTROSE 10GM/100ML · INJECTABLE · INJECTION
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →